ASIRs, per 100 000 population per year, for selected cancer sites, in Pakistan, India, Iran, Israel and the USA
| Pakistan | Globocan | Pakistan | India | Iran | Saudi Arabia | Israel | USA | |
|---|---|---|---|---|---|---|---|---|
| Lahore | Pakistan | Karachi | New Delhi | Golestan | Riyadh | Jews | SEER | |
| 2010–2012 | 2012 | 1998–2002 | 2003–2007 | 2005–2007 | 2003–2007 | 2003–2007 | 2003–2007 | |
| Oral cavity and salivary glands-C00-C08 | ||||||||
| Male | 4.6 | 10.5 | 22.5 | 14.0 | 1.7 | 1.6 | 3.3 | 6.9 |
| Female | 3.9 | 9.1 | 20.4 | 4.7 | 1.3 | 1.4 | 2.3 | 3.1 |
| Pharynx-C09-C14 | ||||||||
| Male | 0.6 | 3.8 | 8.2 | 6.6 | 1.0 | 2.4 | 1.5 | 4.4 |
| Female | 0.8 | 1.3 | 3.4 | 1.5 | 0.7 | 1.3 | 0.5 | 1.1 |
| Oesophagus-C15 | ||||||||
| Male | 1.4 | 3.9 | 6.7 | 4.9 | 23.2 | 1.6 | 1.8 | 5.1 |
| Female | 1.2 | 4.4 | 8.6 | 2.9 | 18.8 | 1.3 | 0.9 | 1.2 |
| Stomach-C16 | ||||||||
| Male | 1.6 | 3.8 | 6.0 | 3.2 | 30.4 | 4.4 | 10.0 | 6.6 |
| Female | 1.3 | 2.2 | 3.6 | 1.5 | 12.6 | 2.3 | 5.4 | 3.3 |
| Small intestine-C17 | ||||||||
| Male | 0.3 | – | 0.2 | 0.2 | 1.4 | 0.5 | 1.0 | 1.5 |
| Female | 0.2 | – | 0.4 | 0.1 | 0.9 | 0.3 | 0.7 | 1.1 |
| Colorectum-C18-C21 | ||||||||
| Male | 4.7 | 4.7 | 7.1 | 5.5 | 13.6 | 12.5 | 42.8 | 35.3 |
| Female | 3.7 | 3.3 | 5.2 | 3.7 | 10.4 | 10.6 | 32.6 | 26.5 |
| Liver-C22 | ||||||||
| Male | 3.7 | 4.7 | 5.4 | 2.6 | 3.6 | 3.0 | 3.1 | 7.6 |
| Female | 2.4 | 2.5 | 3.7 | 1.5 | 2.0 | 6.0 | 1.4 | 2.4 |
| Gall bladder-C23-C24 | ||||||||
| Male | 1.0 | 0.9 | 1.3 | 4.0 | 1.2 | 1.2 | 1.7 | 1.7 |
| Female | 1.9 | 2.2 | 4.9 | 8.0 | 1.6 | 2.5 | 1.4 | 1.7 |
| Pancreas-C25 | ||||||||
| Male | 0.6 | 0.5 | 0.9 | 1.9 | 2.8 | 3.2 | 8.6 | 8.2 |
| Female | 0.5 | 0.4 | 0.5 | 1.1 | 1.0 | 1.9 | 6.4 | 6.2 |
| Nose and sinuses-C30-C31 | ||||||||
| Male | 0.3 | – | 0.7 | 0.3 | 0.0 | 0.2 | 0.4 | 0.6 |
| Female | 0.3 | – | 0.4 | 0.2 | 0.2 | 0.2 | 0.3 | 0.4 |
| Larynx-C32 | ||||||||
| Male | 2.0 | 5.0 | 10.7 | 8.0 | 4.1 | 1.7 | 4.1 | 4.3 |
| Female | 0.3 | 0.7 | 1.8 | 1.1 | 1.4 | 0.1 | 0.6 | 0.9 |
| Trachea, bronchus and lung-C33-C34 | ||||||||
| Male | 4.6 | 9.8 | 25.2 | 13.7 | 17.5 | 6.3 | 29.8 | 48.3 |
| Female | 1.2 | 1.7 | 3.6 | 3.6 | 5.6 | 2.2 | 13.4 | 33.8 |
| Bone-C40-C41 | ||||||||
| Male | 0.9 | – | 1.3 | 2.0 | 1.3 | 0.8 | 1.3 | 1.0 |
| Female | 0.6 | – | 1.5 | 1.2 | 1.5 | 0.5 | 1.0 | 0.8 |
| Melanoma of the skin-C43 | ||||||||
| Male | 0.1 | 0.3 | 0.5 | 0.2 | 0.9 | 0.3 | 13.7 | 16.8 |
| Female | 0.1 | 0.2 | 0.3 | 0.2 | 0.7 | 0.4 | 11.2 | 12.0 |
| Skin-C44 | ||||||||
| Male | 2.8 | – | 4.3 | 1.3 | 11.0 | 3.8 | 2.8 | 1.3 |
| Female | 2.7 | – | 4.1 | 1.0 | 7.7 | 3.2 | 1.9 | 1.0 |
| Connective and soft tissue-C47-C49 | ||||||||
| Male | 1.2 | – | 2.4 | 1.5 | 2.1 | 1.3 | 3.2 | 3.0 |
| Female | 1.0 | – | 2.3 | 1.2 | 2.1 | 0.9 | 2.2 | 2.1 |
| Breast-C50 | ||||||||
| Male | 0.8 | – | 1.0 | 1.3 | 0.1 | 0.5 | 1.3 | 0.7 |
| Female | 47.6 | 50.3 | 69.0 | 31.6 | 28.0 | 21.1 | 89.4 | 86.6 |
| Cervix uteri-C53 | ||||||||
| Female | 2.9 | 7.9 | 7.5 | 17.7 | 5.4 | 2.0 | 5.5 | 6.4 |
| Corpus uteri-C54 | ||||||||
| Female | 3.6 | 3.6 | 6.7 | 4.5 | 1.7 | 4.4 | 14.4 | 16.7 |
| Ovary-C56-C57.0-4 | ||||||||
| Female | 5.1 | 5.6 | 8.8 | 8.6 | 6.1 | 3.3 | 9.2 | 9.6 |
| Other female genital organs-C51-C52, C55, C58 | ||||||||
| Female | 1.5 | – | 1.0 | 1.6 | 1.4 | 0.9 | 1.8 | 2.5 |
| Penis-C60 | ||||||||
| Male | – | – | 0.1 | 1.0 | 0.0 | 0.1 | 0.3 | 0.7 |
| Prostate-C61 | ||||||||
| Male | 6.4 | 6.6 | 10.1 | 10.1 | 10.6 | 7.9 | 68.3 | 106.8 |
| Testis-C62 | ||||||||
| Male | 0.6 | 0.9 | 1.2 | 0.6 | 2.3 | 0.6 | 4.7 | 4.9 |
| Kidney, etc -C64, C66, C68 | ||||||||
| Male | 1.7 | 1.7 | 1.9 | 2.7 | 2.2 | 3.8 | 13.9 | 137.0 |
| Female | 1.1 | 0.9 | 0.8 | 1.2 | 1.2 | 2.5 | 6.5 | 7.1 |
| Bladder-C67 | ||||||||
| Male | 5.0 | 5.1 | 9.3 | 6.5 | 8.5 | 5.6 | 25.5 | 20.8 |
| Female | 1.5 | 1.6 | 2.6 | 1.5 | 2.8 | 1.3 | 4.8 | 5.3 |
| Eye-C69 | ||||||||
| Male | 0.5 | – | 0.6 | 0.3 | 0.4 | 0.4 | 0.6 | 0.8 |
| Female | 0.4 | – | 0.3 | 0.2 | 0.2 | 0.2 | 0.4 | 0.6 |
| Brain, CNS-C70-C72 | ||||||||
| Male | 3.8 | 3.4 | 3.3 | 3.8 | 7.8 | 3.5 | 6.7 | 6.4 |
| Female | 2.2 | 2.1 | 2.7 | 2.4 | 5.3 | 2.1 | 5.0 | 4.6 |
| Thyroid-C73 | ||||||||
| Male | 0.7 | 0.7 | 0.7 | 1.1 | 1.2 | 2.5 | 4.8 | 3.9 |
| Female | 2.2 | 2.2 | 2.9 | 2.5 | 3.0 | 10.2 | 14.7 | 12.3 |
| Adrenal and other endocrine-C74-C75 | ||||||||
| Male | 0.1 | – | 0.2 | 0.2 | 0.7 | 0.3 | 0.6 | 0.5 |
| Female | 0.0 | – | 0.3 | 0.2 | 0.4 | 0.2 | 0.5 | 0.4 |
| Hodgkin lymphoma-C81 | ||||||||
| Male | 1.4 | 2.2 | 2.0 | 1.6 | 1.8 | 2.2 | 3.6 | 2.7 |
| Female | 0.7 | 0.8 | 1.0 | 0.7 | 1.1 | 2.0 | 3.4 | 2.2 |
| NHL-C82-C88, C96 | ||||||||
| Male | 4.5 | 5.3 | 7.6 | 5.6 | 7.2 | 8.6 | 17.9 | 15.5 |
| Female | 3.3 | 3.4 | 5.1 | 3.0 | 3.3 | 7.1 | 14.4 | 10.8 |
| Multiple myeloma-C88, C90 | ||||||||
| Male | 0.6 | 0.7 | 1.8 | 2.0 | 2.4 | 1.8 | 4.8 | 4.7 |
| Female | 0.5 | 0.6 | 1.3 | 1.2 | 2.2 | 1.0 | 3.0 | 3.1 |
| Leukaemia-C91-C95 | ||||||||
| Male | 2.4 | 3.3 | 4.8 | 5.6 | 10.8 | 5.7 | 10.6 | 11.1 |
| Female | 1.5 | 2.2 | 4.1 | 3.6 | 7.7 | 4.3 | 6.9 | 7.1 |
| All sites-C00-C96 | ||||||||
| Male | 66.7 | 96.0 | 166.6 | 119.7 | 165.3 | 104.1 | 273.1 | 359.4 |
| Female | 105.1 | 127.7 | 192.0 | 118.4 | 142.0 | 103.9 | 308.5 | 282.6 |
ASIR, The Age-Standardized Incidence Rates; NHL, Non-Hodgkin lymphoma.